192 related articles for article (PubMed ID: 25630291)
1. [Direct oral anticoagulants and drug-drug interactions].
Graf L; Korte W
Ther Umsch; 2015 Feb; 72(2):99-104. PubMed ID: 25630291
[TBL] [Abstract][Full Text] [Related]
2. Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism.
Brekelmans MP; Kappelhof M; Nieuwkerk PT; Nierman M; Buller HR; Coppens M
Neth J Med; 2017 Mar; 75(2):50-55. PubMed ID: 28276323
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants: new drugs and new concepts.
Levy JH; Spyropoulos AC; Samama CM; Douketis J
JACC Cardiovasc Interv; 2014 Dec; 7(12):1333-51. PubMed ID: 25523529
[TBL] [Abstract][Full Text] [Related]
4. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
[TBL] [Abstract][Full Text] [Related]
5. Direct Oral Anticoagulants in Emergency Trauma Admissions.
Maegele M; Grottke O; Schöchl H; Sakowitz OA; Spannagl M; Koscielny J
Dtsch Arztebl Int; 2016 Sep; 113(35-36):575-82. PubMed ID: 27658470
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring of coagulation during treatment with direct oral anticoagulants].
Kasper A; Lindhoff-Last E
Dtsch Med Wochenschr; 2013 Oct; 138(40):1997-2000. PubMed ID: 24065404
[No Abstract] [Full Text] [Related]
7. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis.
Hum J; Shatzel JJ; Jou JH; Deloughery TG
Eur J Haematol; 2017 Apr; 98(4):393-397. PubMed ID: 28009449
[TBL] [Abstract][Full Text] [Related]
8. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
[TBL] [Abstract][Full Text] [Related]
9. [Use of direct oral anticoagulants in the elderly].
Mickley F; Geigenmüller G; Schinköthe C
Dtsch Med Wochenschr; 2015 Dec; 140(24):1810-2. PubMed ID: 26625228
[TBL] [Abstract][Full Text] [Related]
10. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
Beyer-Westendorf J; Ageno W
Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
[TBL] [Abstract][Full Text] [Related]
11. Use of anticoagulants in elderly patients.
Bauersachs RM
Thromb Res; 2012 Feb; 129(2):107-15. PubMed ID: 22014849
[TBL] [Abstract][Full Text] [Related]
12. New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs).
van Gorp RH; Schurgers LJ
Nutrients; 2015 Nov; 7(11):9538-57. PubMed ID: 26593943
[TBL] [Abstract][Full Text] [Related]
13. Direct oral anticoagulants (DOACs).
Vazquez S; Rondina MT
Vasc Med; 2015 Dec; 20(6):575-7. PubMed ID: 26285587
[TBL] [Abstract][Full Text] [Related]
14. Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.
Zoppellaro G; Granziera S; Padayattil Jose S; Denas G; Bracco A; Iliceto S; Pengo V
Expert Opin Drug Saf; 2015 May; 14(5):683-95. PubMed ID: 25803739
[TBL] [Abstract][Full Text] [Related]
15. [An overview: new direct oral anticoagulants (DOAC)].
Hoffmeister HM
Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):174-9; quiz 180. PubMed ID: 24711237
[TBL] [Abstract][Full Text] [Related]
16. [Oral anticoagulation with vitamin K antagonists].
Alberio L
Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
[TBL] [Abstract][Full Text] [Related]
17. [Management of vitamin K antagonists in the elderly].
Belleville T; Pautas É; Gaussem P; Siguret V
Ann Biol Clin (Paris); 2014; 72(2):185-92. PubMed ID: 24736138
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of vitamin K antagonist overcoagulation.
Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
[TBL] [Abstract][Full Text] [Related]
19. Current challenges and future prospects in oral anticoagulant therapy.
Czuprynska J; Patel JP; Arya R
Br J Haematol; 2017 Sep; 178(6):838-851. PubMed ID: 28573648
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair.
Paparella D; Di Mauro M; Bitton Worms K; Bolotin G; Russo C; Trunfio S; Scrofani R; Antona C; Actis Dato G; Casabona R; Colli A; Gerosa G; Renzulli A; Serraino F; Scrascia G; Zaccaria S; De Bonis M; Taramasso M; Delgado L; Tritto F; Marmo J; Parolari A; Myaseodova V; Villa E; Troise G; Nicolini F; Gherli T; Whitlock R; Conte M; Barili F; Gelsomino S; Lorusso R; Sciatti E; Marinelli D; Di Giammarco G; Calafiore AM; Sheikh A; Alfonso JJ; Glauber M; Miceli A;
J Thorac Cardiovasc Surg; 2016 May; 151(5):1302-8.e1. PubMed ID: 26832208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
